Curis Inc (CRIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRIS | AZN | AMGN | GILD | VRTX |
| Company | Curis Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1700 | 90.29 | 326.27 | 121.24 | 449.74 |
| High | 1.2000 | 91.14 | 328.24 | 122.29 | 452.63 |
| Low | 1.1700 | 90.19 | 321.91 | 120.96 | 446.70 |
| Latest | 1.1800 | 90.89 | 326.12 | 121.63 | 447.49 |
| Change | +0.0100 | +1.03 | +0.11 | +0.27 | -2.03 |
| % Change | +0.85% | +1.15% | +0.03% | +0.22% | -0.45% |
| Volume | 5,399 | 2,468,816 | 920,824 | 1,627,662 | 300,365 |
| 20-Day Average Volume | 109,818 | 5,639,961 | 2,793,142 | 6,866,396 | 1,340,833 |
| Previous Close | 1.1700 | 89.86 | 326.01 | 121.36 | 449.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2340 | 90.93 | 331.02 | 123.07 | 441.71 |
| 20-Day Raw Stochastic | 26.48% | 42.46% | 41.27% | 32.19% | 66.16% |
| 20-Day Relative Strength | 42.00 | 56.36 | 52.88 | 49.73 | 56.95 |
| Weighted Alpha | -58.56 | +41.11 | +24.05 | +28.39 | +11.72 |
| Today's Opinion | 100% Sell | 88% Buy | 72% Buy | 56% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 100% Buy | 100% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.30% since 12/11/25 | +0.55% since 12/11/25 | +2.85% since 12/11/25 | -1.34% since 12/11/25 | +0.69% since 12/11/25 |
| Low | 1.1350 on 12/15/25 | 89.28 on 12/12/25 | 315.19 on 12/12/25 | 118.17 on 12/16/25 | 444.81 on 12/12/25 |
| High | 1.3200 on 12/12/25 | 91.79 on 12/15/25 | 330.04 on 12/17/25 | 123.63 on 12/12/25 | 459.05 on 12/16/25 |
| 1-Month | |||||
| %Chg | -4.88% since 11/18/25 | +1.38% since 11/18/25 | -5.11% since 11/18/25 | -4.42% since 11/18/25 | +3.10% since 11/18/25 |
| Low | 1.0600 on 11/19/25 | 88.41 on 11/20/25 | 312.39 on 12/11/25 | 118.17 on 12/16/25 | 418.53 on 11/19/25 |
| High | 1.4199 on 12/05/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | -31.98% since 09/18/25 | +17.80% since 09/18/25 | +18.34% since 09/18/25 | +6.99% since 09/18/25 | +15.99% since 09/18/25 |
| Low | 1.0600 on 11/19/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.7574 on 09/19/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | -49.13% since 06/18/25 | +28.31% since 06/18/25 | +12.70% since 06/18/25 | +12.56% since 06/18/25 | +0.14% since 06/18/25 |
| Low | 1.0600 on 11/19/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 2.4821 on 07/01/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 15,127 | 278,694,144 | 175,550,208 | 150,568,928 | 114,051,760 |
| Shares Outstanding, K | 12,929 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 10,910,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -43,390,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 3,180,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -7,730,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 4.02 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.49 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/30/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.99 | 14.94 | 14.50 | 29.72 |